Produktname:1-(1H-imidazol-2-yl)cyclobutan-1-ol
IUPAC Name:1-(1H-imidazol-2-yl)cyclobutan-1-ol
- CAS:2155856-15-6
- Molekulare Formel:C7H10N2O
- Reinheit:95%+
- Katalognummer:CM416679
- Molekulargewicht:138.17
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:2155856-15-6
- Molekulare Formel:C7H10N2O
- Schmelzpunkt:-
- SMILES-Code:OC1(CCC1)C1=NC=CN1
- Dichte:
- Katalognummer:CM416679
- Molekulargewicht:138.17
- Siedepunkt:
- Mdl-Nr.:MFCD31615569
- Lagerung:
Category Infos
- Imidazoles
- Imidazole is an important five-membered nitrogen-containing heterocyclic compound. Among the numerous heterocyclic compounds, imidazole and its derivatives are regarded as a unique and multifaceted scaffold material due to their diverse applications in industrial, organic and pharmaceutical chemistry. Imidazoles interact in different ways with many therapeutic targets, enzymes and receptors in biological systems and thus exhibit a wide range of biological activities. In particular, several imidazoles can be used as clinical drugs to treat various types of cancer with high therapeutic efficacy. Furthermore, imidazoles are one of the most critical segments in the field of anti-covid-19 virus drug discovery due to their ability to interact with active targets in living systems.
- Imidazole Manufacturer
- As a professional imidazole manufacturer, we can guarantee product quality and delivery time.our company has been committed to supply personalized product solutions to customers,pls consult us.
- Cyclobutanes
- The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.